EGFR and glioblastoma: Including now specific genetic events into diagnostics, microvascular proliferation or necrosis or one of the following genetic alterations such as telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) gene amplification, and +7/−10 chromosome copy number changes are sufficient to diagnose GBM [16,17].